improving the speed and efficiency of patient care, automatic detection of abnormal cardiovascular activity in real time, and monitoring physiological variables in patients with coronary conditions.
HeartBeam (NASDAQ: BEAT), reported steady progress in its third quarter financial and operational results, advancing its cardiac care technology through key FDA 510(k) submissions and strategic ...
HeartBeam (NASDAQ: BEAT), reported steady progress in its third quarter financial and operational results, advancing its cardiac care technology through key FDA 510(k) submissions and strategic ...
At the Cardiology Summa2024 in Delhi, experts highlighted AI's transformative impact on cardiac care. Dr. Balbir Singh and Dr. Gurpreet Sandhu emphasized AI's role in early heart disease detection ...